IS2487B - Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á - Google Patents

Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á

Info

Publication number
IS2487B
IS2487B IS7641A IS7641A IS2487B IS 2487 B IS2487 B IS 2487B IS 7641 A IS7641 A IS 7641A IS 7641 A IS7641 A IS 7641A IS 2487 B IS2487 B IS 2487B
Authority
IS
Iceland
Prior art keywords
preparation
therapeutic use
acyloxypyrrolidine
derivatives
acyloxypyrrolidine derivatives
Prior art date
Application number
IS7641A
Other languages
English (en)
Other versions
IS7641A (is
Inventor
Aulombard Alain
Garcia Georges
Pradines Antoine
Serradeil-Le Gal Claudine
Wagnon Jean
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS7641A publication Critical patent/IS7641A/is
Publication of IS2487B publication Critical patent/IS2487B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IS7641A 2002-07-19 2005-01-12 Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á IS2487B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0209242A FR2842527B1 (fr) 2002-07-19 2002-07-19 Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
PCT/FR2003/002262 WO2004009585A2 (fr) 2002-07-19 2003-07-17 Derives d'acyloxypyrrolidine et leur utilisation en tant que ligands des recepteurs v1b et v1a de avp

Publications (2)

Publication Number Publication Date
IS7641A IS7641A (is) 2005-01-12
IS2487B true IS2487B (is) 2008-12-15

Family

ID=29797610

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7641A IS2487B (is) 2002-07-19 2005-01-12 Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á

Country Status (28)

Country Link
US (1) US7202267B2 (is)
EP (1) EP1525198B1 (is)
JP (1) JP4264414B2 (is)
CN (1) CN100425608C (is)
AR (1) AR040571A1 (is)
AT (1) ATE312092T1 (is)
AU (1) AU2003271815B8 (is)
BR (1) BR0312800A (is)
CA (1) CA2492224A1 (is)
DE (1) DE60302670T2 (is)
DK (1) DK1525198T3 (is)
EA (1) EA008444B1 (is)
ES (1) ES2254962T3 (is)
FR (1) FR2842527B1 (is)
HK (1) HK1074444A1 (is)
HR (1) HRP20041231A2 (is)
IL (1) IL165942A (is)
IS (1) IS2487B (is)
ME (1) MEP12408A (is)
MX (1) MXPA05000822A (is)
NO (1) NO20050292L (is)
NZ (1) NZ537615A (is)
PL (1) PL375309A1 (is)
RS (1) RS20050018A (is)
TW (1) TWI274751B (is)
UA (1) UA78805C2 (is)
WO (1) WO2004009585A2 (is)
ZA (1) ZA200500478B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1659121A4 (en) 2003-08-28 2008-11-26 Taisho Pharmaceutical Co Ltd D RIV OF 1,3-DIHYDRO-2H-INDOL-2-ONE
TW200643015A (en) 2005-03-11 2006-12-16 Akzo Nobel Nv 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
DE102005015957A1 (de) * 2005-03-31 2006-10-05 Abbott Gmbh & Co. Kg Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
AU2006255009B2 (en) 2005-06-07 2011-10-27 Pharmacopeia L.L.C. Azinone and diazinone V3 inhibitors for depression and stress disorders
AU2007296634B2 (en) 2006-09-11 2012-09-20 Merck Sharp & Dohme B.V. Quinazolinone and isoquinolinone acetamide derivatives
CN103864658B (zh) * 2014-03-06 2016-06-15 南京工业大学 氮杂环丁酮衍生物及其制备方法与应用
CN104447489B (zh) * 2014-12-29 2017-01-11 南京工业大学 3,4-二芳基马来酰亚胺衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804114B1 (fr) * 2000-01-25 2002-03-08 Sanofi Synthelabo Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
IL165942A0 (en) 2006-01-15
TWI274751B (en) 2007-03-01
NO20050292L (no) 2005-04-19
BR0312800A (pt) 2005-04-19
CA2492224A1 (en) 2004-01-29
FR2842527B1 (fr) 2005-01-28
AR040571A1 (es) 2005-04-13
ATE312092T1 (de) 2005-12-15
MEP12408A (en) 2010-06-10
AU2003271815B2 (en) 2009-03-12
RS20050018A (en) 2007-06-04
WO2004009585A2 (fr) 2004-01-29
DK1525198T3 (da) 2006-04-18
US20050192335A1 (en) 2005-09-01
TW200410957A (en) 2004-07-01
DE60302670T2 (de) 2006-09-07
FR2842527A1 (fr) 2004-01-23
CN1681806A (zh) 2005-10-12
MXPA05000822A (es) 2005-08-29
IS7641A (is) 2005-01-12
JP2005537271A (ja) 2005-12-08
PL375309A1 (en) 2005-11-28
US7202267B2 (en) 2007-04-10
AU2003271815B8 (en) 2009-04-30
WO2004009585A3 (fr) 2004-05-06
CN100425608C (zh) 2008-10-15
IL165942A (en) 2010-04-15
ZA200500478B (en) 2006-07-26
EP1525198B1 (fr) 2005-12-07
EA200500032A1 (ru) 2005-08-25
AU2003271815A1 (en) 2004-02-09
EP1525198A2 (fr) 2005-04-27
DE60302670D1 (de) 2006-01-12
HRP20041231A2 (en) 2005-02-28
UA78805C2 (en) 2007-04-25
HK1074444A1 (en) 2005-11-11
NZ537615A (en) 2006-11-30
ES2254962T3 (es) 2006-06-16
JP4264414B2 (ja) 2009-05-20
EA008444B1 (ru) 2007-06-29

Similar Documents

Publication Publication Date Title
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
IS7079A (is) Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
IS6661A (is) Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
NO20051983D0 (no) 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
NO20053593D0 (no) Arylalkylkarbamat-derivater, fremgangsmate og anvendelse derav i terapi
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
DK1525193T3 (da) Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20053805D0 (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
NO20044090L (no) Substituert 3-fenyl-5-alkoksy-1,3,4-oksadiazol-24neJr, fremstilling derav og anvendelse i medikamenter
IS6391A (is) 2-Arýlkínólín afleiður, framleiðsla og meðferðarleg notkun á þeim
DK1309594T3 (da) Benzimidazolderivater, fremstilling heraf og terapeutisk anvendelse heraf
SI1513835T1 (sl) Derivati piperazunilacilpiperidina, njihova priprava in njihova terapevtska uporaba
SI1513836T1 (sl) Derivati piperazinilacilpiperidina, njihova priprava in njihova terapevtska uporaba
SI1525198T1 (sl) Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP
SI1525193T1 (sl) Acilaminotiazolni derivati in njihova uporaba kotinhibitorji beta-amiloida